DocMorris AGCHIX:DOCMZ -0.31%67 Days Payable is 24.76 as of Jun. 2025, which is 18% below its 10-year median of 30.15. GuruFocus rates CHIX:DOCMZ with a GF Score™ of 67/100 and a GF Value™ of CHF10.54 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 608 Healthcare Providers & Services companies, DocMorris AG ranks worse than 79.44% on this metric.
The historical rank and industry rank for DocMorris AG's Days Payable or its related term are showing as below:
CHIX:DOCMz'
s Days Payable Range Over the Past 10 Years
Min: 22.31 Med: 30.15 Max: 58
Current: 24.19
During the past 13 years, DocMorris AG's highest Days Payable was 58.00. The lowest was 22.31. And the median was 30.15.
CHIX:DOCMz's Days Payable is ranked worse than 79.44% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs CHIX:DOCMz: 24.19
DocMorris AG's Days Payable
increased
from Jun. 2024 (21.06) to Jun. 2025 (24.76).
It may suggest that DocMorris AGdelayed paying its suppliers.
DocMorris AG Days Payable Related Terms
DocMorris AG Days Payable Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, DocMorris AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Days Payable distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
DocMorris AG's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (CHIX:DOCMZ) has a Days Payable of 24.76 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DocMorris AG and its competitors. This is 18% below median its historical median of 30.15. Over the past decade, DocMorris AG's Days Payable has ranged from 22.31 to 58.00. According to the industry distribution chart, DocMorris AG ranks #483 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 79.4%.
Is DocMorris AG's Days Payable too high?
DocMorris AG's current Days Payable of 24.76 is 18% below median its 10-year median of 30.15. Over the past 10 years, this metric has ranged from a low of 22.31 to a high of 58.00. The Healthcare Providers & Services industry median Days Payable is 58.08. DocMorris AG's value of 24.76 is 57.4% below this industry median. Based on the distribution chart, DocMorris AG ranks #483 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DocMorris AG has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #483 out of 608 companies for Days Payable. This places DocMorris AG in the lower half of its industry. The industry median Days Payable is 58.08. DocMorris AG's value of 24.76 is 57.4% below this benchmark. Historically, DocMorris AG's own Days Payable has ranged from 22.31 to 58.00 over the past decade. While the company's 10-year median is 30.15 vs. the industry median of 58.08, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Days Payable of 24.76 is 57.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Days Payable is 24.76, which is 18% below median its own 10-year median of 30.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (CHIX:DOCMZ) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.54, compared to a current price of CHF7.92 — trading 24.9% below its estimated fair value. The current Days Payable is 24.76, which is 18% below median its 10-year median of 30.15 and 57.4% below the Healthcare Providers & Services industry median of 58.08. DocMorris AG's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For DocMorris AG (CHIX:DOCMZ), the current Days Payable is 24.76 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (CHIX:DOCMZ) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF7.92 is trading 24.9% below its estimated GF Value™ of CHF10.54.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for CHIX:DOCMZ:
Days Payable: 24.76 (18% below median its 10-year median of 30.15)
GF Value™: CHF10.54 vs. price of CHF7.92 (24.9% below fair value)
Industry Position: 57.4% below the Healthcare Providers & Services median (#483 of 608)
No single metric tells the full story. See the CHIX:DOCMZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
67GF Score
Get the complete analysis for CHIX:DOCMZ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DOCMZ has been successfully added to your 
